Nehmen Sie Kontakt auf.

Zur Kontaktliste

Haben Sie Fragen zu Services oder zum Literaturangebot von ZB MED? Benötigen Sie Tipps zur Recherche in LIVIVO?

Kontakt

info@zbmed.de
Telefonnummer: +49 (0)221 999 892 240

Köln

Medizin und Gesundheitswesen

Adresse:
ZB MED – Informationszentrum Lebenswissenschaften
Gleueler Straße 60
50931 Köln

Bonn

Ernährungs-, Umwelt- und Agrarwissenschaften

Adresse:
ZB MED – Informationszentrum Lebenswissenschaften
Friedrich-Hirzebruch-Allee 4
53115 Bonn

InfoCenter

INFORMATION.

WISSEN.
LEBEN.

Infrastruktur- und Forschungszentrum für lebenswissenschaftliche Daten und Informationen.

Thema Lebenswissenschaften?

Wir haben die Werkzeuge für Ihre passgenauen Recherchen.

Kongressdetails

02.03.2020 - 04.03.2020

EACR-AACR-ASPIC 2020 Conference: Tumor Microenvironment

Veranstaltungsort
Lisbon Congress Centre, Lisbon
Kontakt und Ansprechparter

For queries relating to registration, abstracts and Visas, please contact Covr - eaa2020@covr.be


For all other queries, please contact Wessel Nieuwenweg - hello@eaa2020.org

Land
Portugal
Fachdisziplin(en)
Kurzinfo

The European Association for Cancer Research (EACR), American Association for Cancer Research (AACR) and Associação Portuguesa de Investigação em Cancro (ASPIC) are proud to announce this new joint Basic and Translational Research Conference on Tumor Microenvironment, to be held in Lisbon, Portugal, 02-04 March 2020.


This EACR-AACR-ASPIC conference on Tumor Microenvironment (TME) will bring together thought leaders spanning the breadth of TME, immune-oncology, computational biology and biomedical technology disciplines to discuss novel approaches to identify critical mechanisms regulating the crosstalk in these tumor ecosystems. We will also discuss therapeutic approaches to target the TME for durable tumor control, including strategies being deployed in patients, and initial clinical findings. The goal will be to not only discuss the current state of the TME field, but also discuss approaches towards applying that knowledge to the development of effective and broadly applicable anti-cancer therapies for long-term management of disease.